Alibaba Group appears to be prepping a Hong Kong stock offering that could be worth $20 billion, and give a vote of confidence at a time of great tumult.
There's a lot going on right now and the markets (and media) have difficulty latching on to more than three or four stories at a time.
Right now, the Fed has to be worried about how much inflation the next round of tariffs is going to cause versus how much the tariffs will hurt our growth.
The initial public offering of Hansoh Pharmaceutical Group made the Chinese couple Zhong Huijuan and Sun Piaoyang the richest in the nation.
Jamie Dimon also expresses concern about the impact of China tariffs and a fresh GDP estimate is at hand.
As African swine flu cuts pork supply in China, Tyson could be a counter-intuitive winner amidst Chinese pork shortages.
The company's expansion beyond its North American home base could offer the most upside to the stock as it continues its surge.
The maker of athletic apparel continues to take a larger lead over its retail peers.
Tesla's tight battery supply could be accelerating the need for a new solution.
The retailer's disappointing first-quarter results and outlook plus the impact of tariffs combine to put its stock in value territory; the question is whether the tariffs will stick.
Elon Musk is helping move the shares after a big Tuesday meeting.
A Hong Kong-listed mainland Chinese property developer has shelved the purchase of a billion-dollar land plot in the city, walking away from a hefty deposit. It blames political chaos.
In Trump's view the tariffs force the Chinese to pay our government money and therefore it is a win win.
Luckin Coffee's strategy of getting Chinese drinkers hooked on java makes the company good for an aggressive play.
President Trump uses economic leverage instead of infantry divisions to defend U.S. interests, and Advanced Micro Devices regains lost ground.
Does Hong Kong become "just another Chinese city" with its proposed extradition law? Many critics say the city's special status within greater China is slipping away.
Our brewing Cold War over regional and global spheres of influence with China, has forced some merger activity across the aerospace and defense industry.
Growth and profitability are a great complement to a recent IPO and Tencent Music has both.
Chinese authorities are auditing the books of 77 drugmakers, including three multinationals, they say were selected at random. Were they motivated by embarrassment over a college-admissions payment made by a Chinese pharmaceuticals' tycoon?
As Jim Cramer noted,'Nothing is worse than fluid.' That's just how Five Below sees the trade situation.
FIVE could provide a modicum of comfort to retail investors run ragged in recent weeks.
Reuters found itself in the strange position of writing a news story to explain why its news stories about the Tiananmen Square massacre weren't appearing on an investment-data platform it created.
You know where the firm has next to no revenue exposure? China.
Can markets go higher? Certainly, but we still need to see higher prices form here on higher volumes in order to confirm that those big kids are playing ball.
Nothing changed Tuesday as far as trade with China and Mexico and there was no major improvement in economic news.
Comments from China, Mexico and the Fed led the way.
This may be a case where the short-term damage to markets may be for the best in the longer run.
What happened to the business president? I think what happened is that the polls are showing that whatever the president is doing is working.
South Korea is the plastic surgery capital of the world. These companies are manufacturing botox strains - but the big business is abroad, if they can crack the China and U.S. markets.
Regulators worldwide are looking to rein in Alphabet's business model.